Huaren Pharmaceutical Co Ltd (300110)

Shenzhen

Currency in CNY

3.51

+0.02(+0.57%)

Delayed Data·07:31:00

Fair Value

Unlock Value

Day's Range

3.47

3.54

52 wk Range

2.71

4.32

300110 Financial Summary

A brief financial summary of Huaren Pharmaceutical Co Ltd as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio-2.91

Price/Book3.11

Debt / Equity115.62%

Return on Equity-66.46%

Dividend Yield0.00%

EBITDA246.27M

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2015

31/12

2016

31/12

2018

01/01

2018

31/12

2019

31/12

2020

31/12

2022

01/01

2023

01/01

2023

31/12

2024

31/12

Income Statement

Total Revenues

aa.aa

1,316.59

1,560.86

1,619.49

1,636.26

1,353.16

Gross Profit

aa.aa

554.53

760.15

695.9

695.83

467.55

Operating Income

aa.aa

117.06

226.64

244.58

344.84

130.05

Net Income

aa.aa

94.62

130.4

180.78

188.06

-1,368.48

Balance Sheet

Total Assets

aa.aa

3,415.54

5,641.54

5,162.82

5,165.7

3,428.12

Total Current Liabilities

aa.aa

1,055.46

2,590.73

2,029.43

1,516.26

1,546.63

Total Equity

aa.aa

2,329.51

2,443.43

2,599.73

2,765.96

1,373.93

Cash Flow

Levered Free Cash Flow

aa.aa

-30.09

-634.17

143.72

293.17

1,631.95

Cash from Operations

aa.aa

-10.74

-578.52

217.98

305.6

322.36

Cash from Investing

aa.aa

-237.97

-458.58

-143.81

-97.14

-37.92

Cash from Financing

aa.aa

112.35

1,040.15

-152.67

-120.72

-369.5

Net Change in Cash

aa.aa

-136.33

3.03

-78.5

87.74

-85.07

* In Millions of CNY (except for per share items)

Earnings

Latest Release

Apr 22, 2025

EPS / Forecast

0.01 / --

Revenue / Forecast

303.47M / --

EPS Revisions

Unlock

Last 90 days

FAQ

What were Huaren Pharma's earnings for the latest quarter?

The Huaren Pharma EPS (TTM) is -1.19. Huaren Pharma reported sales of 303.47, net income of 16.03, and EPS of 0.01 for the latest quarter.

What was Huaren Pharma's net income for the latest quarter?

Huaren Pharma's net income for the latest quarter was 16.03.

How did Huaren Pharma's performance compare year-over-year in the latest quarter?

The company's revenue moved from 279.54 in the previous quarter to 303.47 in the latest quarter, and net income moved from -1,464.01 to 16.03 compared to the previous quarter.

What is Huaren Pharma's net profit margin on a TTM basis?

Huaren Pharma's trailing twelve months (TTM) net profit margin is -101.13%.

How does Huaren Pharma's debt to equity ratio compare to industry standards?

Huaren Pharma's total debt-to-equity ratio is 115.62%.

What is Huaren Pharma's return on investment on a TTM basis?

Huaren Pharma's trailing twelve months (TTM) return on investment (ROI) is -66.46%.

Did Huaren Pharma gain or lose cash last quarter?

In the latest quarter, Huaren Pharma's net change in cash was 16.58 million.

What were Huaren Pharma's total assets and liabilities in the latest quarter?

As of the latest quarter, Huaren Pharma reported total assets of 3,450.16 million and total liabilities of 1,624.15 million.

How has Huaren Pharma's total revenue grown this year?

Huaren Pharma's total revenue was 279.54 in the previous quarter and 303.47 in the latest quarter.

What is Huaren Pharma's gross margin on a TTM basis?

Huaren Pharma's trailing twelve months (TTM) gross margin is 32.54%.

What was Huaren Pharma's revenue per share for the latest quarter?

Huaren Pharma's revenue per share for the latest quarter was 6.97.

NSE 30

5,302.92

-8.22

-0.15%

NSE All Share

145,367.03

-497.75

-0.34%

US 30

45,269.50

+358.2

+0.80%

US 500

6,486.30

+17.8

+0.27%

FTSE 100

9,177.24

+12.01

+0.13%

DAX

24,377.50

+191.91

+0.79%

South Africa Top 40

94,566.19

-280.71

-0.30%

Market Movers

Name	Last	Chg. %	Vol.
Aiico	4.19	-9.89%	236.57M
Ellah Lakes	15.90	-9.97%	99.60M
Access Holdings	27.65	+0.18%	46.41M
Nigerian Breweries	71.50	0.00%	26.10M
First HoldCo	32.85	+0.15%	22.02M
Zenith Bank	72.00	-0.76%	15.85M
Guaranty Trust Holding	97.20	-0.51%	7.86M

Name	Last	Chg. %	Vol.
Juli	9.90	+10.00%	609.06K
Austin Laz	2.33	+9.91%	583.89K
Ncr Nigeria	8.70	+9.43%	301.07K
Thomaswy	3.70	+8.19%	687.77K
Chams	2.95	+8.06%	39.80M
Rtbriscoe	3.96	+5.88%	2.20M
Daarcomm	1.05	+2.94%	11.87M

Name	Last	Chg. %	Vol.
Cileasing	7.20	-10.00%	8.24M
Lasaco Assurance PLC	4.50	-10.00%	47.25M
Sovereign Trust Insurance Plc	3.24	-10.00%	72.27M
UPDC	7.20	-10.00%	6.16M
Wema Bank	20.70	-10.00%	7.76M
International Energy Insurance	3.70	-9.98%	11.35M
Cornerst	7.67	-9.98%	16.11M

Trending Stocks

Name	Last	Chg. %	Vol.
Aiico	4.19	-9.89%	236.57M
Ellah Lakes	15.90	-9.97%	99.60M
Linkassure	2.70	-0.74%	214.27M
Access Holdings	27.65	+0.18%	46.41M
Mutual Benefits Assurance	3.50	-9.79%	157.53M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaa Aaa	577.00	+45.24%	838.03
Aaaaaa	5,379.30	+43.90%	7,740.81
Aa Aaaaaa Aa Aa	1,890.00	+33.66%	2,526.17
Aaaaaaaaaaaa	71.00	+32.78%	94.27
Aaaa Aaaaaa Aaaaa	168.60	+26.20%	212.77
A Aa A Aaa	640.00	+18.51%	758.46

Name	Last	Upside	Fair Value
Aaaaaaaaaaa Aaa	577.00	+45.24%	838.03
Aaaaaa	5,379.30	+43.90%	7,740.81
Aa Aaaaaa Aa Aa	1,890.00	+33.66%	2,526.17
Aaaaaaaaaaaa	71.00	+32.78%	94.27
Aaaa Aaaaaa Aaaaa	168.60	+26.20%	212.77
A Aa A Aaa	640.00	+18.51%	758.46

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Huaren Pharmaceutical Co Ltd (300110)

300110 Financial Summary

Key Ratios

Statements Highlights

Earnings

FAQ

What were Huaren Pharma's earnings for the latest quarter?

What was Huaren Pharma's net income for the latest quarter?

How did Huaren Pharma's performance compare year-over-year in the latest quarter?

What is Huaren Pharma's net profit margin on a TTM basis?

How does Huaren Pharma's debt to equity ratio compare to industry standards?

What is Huaren Pharma's return on investment on a TTM basis?

Did Huaren Pharma gain or lose cash last quarter?

What were Huaren Pharma's total assets and liabilities in the latest quarter?

How has Huaren Pharma's total revenue grown this year?

What is Huaren Pharma's gross margin on a TTM basis?

What was Huaren Pharma's revenue per share for the latest quarter?

Trending Stocks